Intravenous Catheters Market was over USD 8.5 Billion in 2023 and is set to surpass USD 18 Billion by end of the year 2032, growing at over 7.5% CAGR between 2024 and 2032.
Growth Drivers & Opportunity:
One major growth driver for the Intravenous Catheters market is the increasing prevalence of chronic diseases that require continuous monitoring and treatment. Conditions such as diabetes, cardiovascular diseases, and cancer require patients to have access to intravenous therapy, thereby boosting the demand for intravenous catheters. Additionally, the rising geriatric population worldwide is another factor driving market growth, as elderly individuals are more susceptible to various health issues that may necessitate the use of intravenous catheters for treatment. Furthermore, technological advancements in catheter design and materials have improved patient comfort and safety, further fueling market growth.
Another growth driver for the Intravenous Catheters market is the growing focus on infection prevention and control. Healthcare-associated infections are a significant concern in hospitals and other healthcare settings, leading to increased emphasis on the use of sterile and antimicrobial catheters to reduce the risk of infection transmission. With healthcare providers increasingly prioritizing patient safety and quality of care, the demand for advanced intravenous catheters that help prevent infections is expected to grow substantially in the coming years.
Report Coverage | Details |
---|---|
Segments Covered | Product Type, Gauge Size, Lumen, Material, End-Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | AngioDynamics, Argon Medical Devices, Becton, Dickinson and Company, B. Braun Melsungen AG, Boston Scientific, ICU Medical, Medilivescare Manufacturing Pvt.., Medtronic plc, Nipro, Poly Medicure., Teleflex Incorporated, Terumo, Vygon |
One major restraint facing the Intravenous Catheters market is the risk of complications associated with catheter insertion and use. Complications such as infection, thrombosis, and phlebitis can occur during or after catheter placement, leading to adverse patient outcomes and increased healthcare costs.
North America: The North America region, which includes the United States and Canada, is expected to hold a significant share in the Intravenous Catheters Market. The presence of a well-established healthcare infrastructure, high healthcare expenditure, and increasing prevalence of chronic diseases are some of the factors driving the demand for intravenous catheters in this region. Additionally, the growing geriatric population and the rising number of surgeries and medical procedures are further contributing to market growth in North America.
Asia Pacific: The Asia Pacific region, which includes countries such as China, Japan, and South Korea, is expected to witness rapid growth in the Intravenous Catheters Market. The increasing healthcare expenditure, improving healthcare infrastructure, and rising awareness about healthcare among the population are driving the demand for intravenous catheters in this region. Moreover, the presence of a large patient pool, particularly in countries like China and India, is further fueling market growth in Asia Pacific.
Europe: Europe, which includes countries like the United Kingdom, Germany, and France, is another key region in the Intravenous Catheters Market. The presence of a well-established healthcare system, high adoption rate of advanced medical technologies, and increasing number of surgical procedures are some of the factors driving market growth in Europe. Additionally, the growing prevalence of chronic diseases and the rising geriatric population are further contributing to the demand for intravenous catheters in this region.
Midline Peripheral:
The market size and share for Midline Peripheral intravenous catheters are expected to grow steadily in the coming years. This type of catheter is preferred for patients who require intravenous therapy for a moderate duration, usually up to 6 weeks. The ease of insertion and reduced risk of complications make Midline Peripheral catheters a popular choice among healthcare providers. Market players are focusing on innovating materials and design to enhance the performance of Midline Peripheral catheters, thus driving market growth.
PICC:
Peripherally Inserted Central Catheters (PICC) segment is anticipated to have a significant market share due to the rising prevalence of chronic diseases requiring long-term intravenous therapy. The convenience of PICC lines, which can remain in place for several weeks to months, is driving their adoption in various healthcare settings. Companies are investing in developing advanced technologies to improve the safety and efficiency of PICC lines, thereby propelling market growth.
CVC:
Central Venous Catheters (CVC) segment is expected to witness steady growth in the market, mainly driven by the increasing number of critical care patients requiring central venous access for hemodynamic monitoring and administering medications. The demand for CVCs with multiple lumens and antimicrobial coatings is rising to reduce the risk of infections and improve patient outcomes. Market players are focusing on enhancing the durability and biocompatibility of CVCs to meet the evolving healthcare needs.
Gauge Size:
The market for intravenous catheters based on gauge size is segmented into 14G-16G, 17G-18G, 19G-20G, 21G-22G, and 23G+. The preference for smaller gauge sizes, such as 20G and below, is increasing due to their lower risk of vein damage and patient discomfort. Healthcare providers are choosing catheters with smaller gauges for delicate procedures and pediatric patients. However, larger gauge catheters are still preferred for rapid fluid administration and blood transfusions.
Lumen:
The market segmentation based on the number of lumens includes single, double, and multi-lumen intravenous catheters. Multi-lumen catheters are gaining traction in the market due to their ability to facilitate multiple therapies simultaneously, reducing the need for multiple catheter insertions. Healthcare facilities are increasingly adopting multi-lumen catheters to improve patient comfort, streamline workflow, and reduce the risk of catheter-related complications.
Material:
Intravenous catheters are commonly made of materials such as polyurethane, silicone, and PVC. Polyurethane catheters are preferred for their flexibility, durability, and biocompatibility. Silicone catheters are known for their softness and reduced risk of tissue irritation, making them suitable for long-term use. PVC catheters are cost-effective but may not offer the same level of comfort and safety as polyurethane and silicone catheters. The choice of material depends on factors such as patient condition, duration of catheter use, and cost considerations.
End-use:
The market for intravenous catheters is segmented based on end-use, including hospitals, ambulatory care centers, and specialty clinics. Hospitals are the largest end-users of intravenous catheters due to the high volume of patients requiring intravenous therapy in inpatient settings. Ambulatory care centers and specialty clinics are witnessing an increasing demand for intravenous catheters, driven by advancements in outpatient care and the rising prevalence of chronic diseases. Market players are targeting these end-use segments with tailored products and services to meet the diverse needs of healthcare providers.
The Intravenous Catheters Market is characterized by intense competition among key players who are constantly innovating to bring advanced technologies and products to market. The market is driven by increasing incidence of chronic diseases, rising demand for minimally invasive procedures, and the growing adoption of intravenous therapy. Some of the key players operating in this market include Becton, Dickinson and Company, B. Braun Melsungen AG, Smiths Medical, Terumo Corporation, Teleflex Incorporated, AngioDynamics, Vygon SA, Argon Medical Devices, Romsons International, and Delta Medivault.
Top Market Players:
1. Becton, Dickinson and Company
2. B. Braun Melsungen AG
3. Smiths Medical
4. Terumo Corporation
5. Teleflex Incorporated
6. AngioDynamics
7. Vygon SA
8. Argon Medical Devices
9. Romsons International
10. Delta Medivault